Target intelligence / Profile preview

Mitochondrial electron transport chain complexes I–III (ETC Complexes I–III)

Target
ETC Complexes I–III
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial protein complex
01

Overview

The mitochondrial electron transport chain (ETC) complexes I–III are essential protein assemblies located within the inner mitochondrial membrane that facilitate the transfer of electrons from metabolic substrates to oxygen (Wikipedia, 2026; UBCO, 2026). Complex I (NADH:ubiquinone oxidoreductase) and Complex II (succinate dehydrogenase) initiate this process by oxidizing NADH and FADH2, respectively, and transferring electrons to the mobile carrier ubiquinone (PMC, 2021; Frontiers, 2021). Complex III (ubiquinol-cytochrome c oxidoreductase) then transfers these electrons to cytochrome c, a process coupled with the translocation of protons across the membrane to generate the electrochemical gradient necessary for ATP synthesis (Patsnap, 2024). Beyond energy production, these complexes are the primary cellular sites for reactive oxygen species (ROS) generation, which plays a dual role in signaling and oxidative damage (PubMed, 2011; PMC, 2021). Therapeutically, inhibitors of these complexes are being explored as mitocans to selectively induce apoptosis in cancer cells by disrupting their metabolic adaptation (ResearchGate, 2021). However, because of their central role in systemic energy metabolism, targeting these complexes requires careful management to avoid severe side effects such as lactic acidosis and neurotoxicity (PMC, 2011; SCBT, 2024).

Other names
Mitochondrial respiratory chain complexes I–IIIOXPHOS complexes I–IIIRespiratory chain complexes I–IIIMitochondrial complexes I, II, and III
02

Mechanism of action

Inhibition of electron transfer within the respiratory chain, leading to decreased ATP production and increased reactive oxygen species (ROS) generation.

03

Biological functions

Oxidative phosphorylationATP synthesisReactive oxygen species generationRedox signalingApoptosis regulation
04

Disease associations

CancerNeurodegenerative diseaseMetabolic disorderMitochondrial disease
05

Safety considerations

Lactic acidosisMitochondrial toxicityNeurotoxicityCardiotoxicity
06

Interacting drugs

Metformin

9 more in the full profile.

07

Biomarkers

Oxygen consumption rate (OCR)Mitochondrial membrane potentialReactive oxygen species (ROS) levelsLactate/pyruvate ratioATP levels

Beyond the preview

Go deeper on Mitochondrial electron transport chain complexes I–III (ETC Complexes I–III).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial electron transport chain complexes I–III (ETC Complexes I–III).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call